Stockhorn has announced that the mandatory public cash offer has been declared unconditional and that the acceptance period has been shortened

Stockhorn Capital AB's mandatory public cash offer to acquire all shares in Irisity AB at SEK 0.132 per share, announced 3 December 2025 and detailed in an offer document on 4 December 2025, has been declared unconditional after the Swedish Inspectorate of Strategic Products left Stockhorn’s notification without action. Stockhorn has shortened the acceptance period to expire 7 January 2026 at 15:00 CET, with payment to accepting shareholders expected on or around 13 January 2026; the bidder confirms it will complete the offer. The target, Irisity, is an AI video analytics platform listed on Nasdaq First North Growth Market (ticker IRIS).

Analysis

Market structure: The unconditional SEK 0.132 cash bid crystallizes value and creates a short-duration takeover arbitrage. Winners are Stockhorn (control, potential consolidation/value extraction) and tendering minority holders; losers are holders expecting higher strategic upside or liquidity post-takeover. With regulatory risk largely cleared, the market should compress IRIS's free‐float price toward 0.132 within the next 4–6 weeks, reducing spot volatility but creating basis for capital-efficient arbitrage trades.

Risk assessment: Tail risks include a competing bid (upside but short-lived volatility), post-acquisition asset stripping or write-downs (permanent loss for non-tenderers), and borrowing/settlement failures in a thin market. Immediate horizon (days–weeks): price mean-reversion to offer; short-term (weeks–months): potential squeeze if holdouts push price above offer; long-term (quarters+): delisting risk and loss of public-market optionality. Monitor acceptance rate disclosures and any change to offer price by Jan 7, 2026 — each 1% swing in acceptance implies material residual float and potential price dispersion.

Trade implications: Primary play is takeover arbitrage: buy IRIS if market price <= SEK 0.12 (target 10%+ gross return to 0.132 by ~13 Jan 2026, horizon 4–6 weeks). If IRIS trades >0.132, expect reversion or competing-bid volatility; short small position with strict borrow checks and a 5% stop. Cross-sector: reduce exposure to illiquid Nordic AI/security small-caps (reallocate 1–3% to liquid large-cap AI/GPU exposure: NVDA) to manage idiosyncratic M&A risk.

Contrarian angles: Consensus likely underestimates post-takeover downside for non-tenderers—delisting removes any long-term upside from product commercialization in US/LatAm hubs. Conversely, market may be underpricing the probability of a higher competing bid; historical Nordic acquisitions saw ~5–20% topping bids within weeks. Unintended consequence: shortened acceptance compresses arbitrage window, increasing execution risk for larger positions and amplifying borrow/settlement premium in options/shorts.

Key Decisions for Investors

• Establish a tactical long position in Irisity (ticker IRIS) sized 1–3% NAV if market price <= SEK 0.120; tender at SEK 0.132 expected settlement ~13 Jan 2026. Target gross return ≥10% over ~4–6 weeks; set hard stop at SEK 0.110 (loss ~8–10%).
• If IRIS trades > SEK 0.132, consider a small short (<=1% NAV) only after borrow availability confirmed; cover at SEK 0.132 or earlier if a competing bid is announced. Place stop-loss at +5% above entry to limit squeeze risk.
• Reduce aggregated exposure to illiquid Nordic AI/security small-caps by 1–3% and redeploy into liquid large-cap AI/semiconductor names (e.g., NVDA) to capture secular AI upside while lowering M&A/delisting idiosyncratic risk.
• Monitor these triggers through Jan 7, 2026: (a) any rival bid or offer increase (action: increase long size to up to 3–5% NAV if competing bid appears), (b) weekly acceptance-rate updates and block trades (action: close >50% of position if acceptance <80% and price diverges >3% from offer).